Stockholders' Equity Attributable to Parent in USD of China SXT Pharmaceuticals, Inc. from Q1 2016 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
China SXT Pharmaceuticals, Inc. quarterly Stockholders' Equity Attributable to Parent history and change rate from Q1 2016 to Q1 2025.
  • China SXT Pharmaceuticals, Inc. Stockholders' Equity Attributable to Parent for the quarter ending 31 Mar 2025 was $15.4M, a 10.8% increase year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $15.4M +$1.51M +10.8% 31 Mar 2025 20-F 31 Jul 2025
Q3 2024 $15M +$9.96M +196% 30 Sep 2024 6-K 28 Mar 2025
Q1 2024 $13.9M -$761K -5.18% 31 Mar 2024 20-F 31 Jul 2025
Q3 2023 $5.08M -$9.47M -65.1% 30 Sep 2023 6-K 28 Mar 2025
Q1 2023 $14.7M -$1.39M -8.65% 31 Mar 2023 20-F 31 Jul 2025
Q3 2022 $14.5M +$756K +5.48% 30 Sep 2022 6-K 05 Apr 2024
Q1 2022 $16.1M +$122K +0.76% 31 Mar 2022 20-F 31 Jul 2025
Q3 2021 $13.8M -$4.73M -25.5% 30 Sep 2021 6-K 24 Feb 2023
Q1 2021 $16M +$6.56M +69.8% 31 Mar 2021 20-F 13 Aug 2024
Q3 2020 $18.5M +$7.11M +62.3% 30 Sep 2020 6-K 14 Jan 2022
Q1 2020 $9.4M -$1.71M -15.4% 31 Mar 2020 20-F 31 Jul 2023
Q3 2019 $11.4M +$6.81M +148% 30 Sep 2019 6-K 28 Jan 2021
Q1 2019 $11.1M +$7.82M +238% 31 Mar 2019 20-F/A 19 May 2023
Q3 2018 $4.6M 30 Sep 2018 6-K/A 22 May 2020
Q1 2018 $3.29M +$1.43M +77.4% 31 Mar 2018 20-F 13 Aug 2021
Q1 2017 $1.85M +$1.11M +149% 31 Mar 2017 20-F 31 Jul 2020
Q1 2016 $743K 31 Mar 2016 20-F 15 Aug 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.